Philly Jury Set To Deliberate In Xarelto Injury Case

Law360, Philadelphia (December 1, 2017, 8:42 PM EST) -- A Philadelphia jury was urged during closing arguments on Friday to find that inadequate warnings from a pair of Johnson & Johnson and Bayer AG units for the blood-thinner Xarelto left an Indiana woman suffering a serious gastrointestinal bleed.

The closely watched case, only the fourth set of Xarelto-related product liability claims to go to trial in the United States, came to a close on Friday as attorneys accused Janssen Pharmaceuticals Inc. and Bayer Healthcare Pharmaceuticals Inc. of deliberately understating the risks of serious internal bleeding associated with the blockbuster drug.

“The evidence overwhelmingly concludes that this drug is simply not...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS